Detalles de la búsqueda
1.
Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME.
Cancer Med
; 10(12): 3952-3963, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34080776
2.
UPFRONT DPD DEFICIENCY DETECTION TO SECURE 5-FU ADMINISTRATION: PART 2- APPLICATION TO HEAD-AND-NECK CANCER PATIENTS.
Clin Cancer Drugs
; 4(2): 122-128, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29682445
3.
A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients.
Sci Rep
; 7(1): 2714, 2017 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28578404
4.
Paravertebral Well-Differentiated Liposarcoma with Low-Grade Osteosarcomatous Component: Case Report with 11-Year Follow-Up, Radiological, Pathological, and Genetic Data, and Literature Review.
Case Rep Pathol
; 2017: 2346316, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28377828
5.
Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile.
Cancer Chemother Pharmacol
; 63(6): 1177-80, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19107485
6.
High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.
Anticancer Drugs
; 19(3): 267-73, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18510172
7.
Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation.
Pharmacogenet Genomics
; 17(10): 841-4, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17885621
8.
Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.
Ther Drug Monit
; 28(4): 532-9, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16885721
Resultados
1 -
8
de 8
1
Próxima >
>>